| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品(元) | 831,271,110.19 | - | 1,153,990,176.91 | 2,096,620,117.11 | 1,134,676,371.98 |
| 医药健康产品(元) | - | 2,193,713,814.70 | - | - | - |
| 内部抵销(元) | -259,876.56 | - | - | - | - |
| 其他(元) | 14,929,824.31 | 32,444,116.93 | 16,488,096.27 | 34,140,278.93 | 19,737,105.22 |
| 营业成本(元) | |||||
| 药品(元) | 143,021,112.78 | - | 161,903,334.66 | 331,514,611.68 | 156,253,806.09 |
| 医药健康产品(元) | - | 319,094,344.41 | - | - | - |
| 内部抵销(元) | - | - | - | - | - |
| 其他(元) | 4,328,959.39 | 10,115,008.28 | 4,497,501.14 | 10,161,515.28 | 6,254,614.47 |
| 毛利(元) | |||||
| 药品(元) | 688,249,997.41 | - | 992,086,842.25 | 1,765,105,505.43 | 978,422,565.89 |
| 医药健康产品(元) | - | 1,874,619,470.29 | - | - | - |
| 内部抵销(元) | -259,876.56 | - | - | - | - |
| 其他(元) | 10,600,864.92 | 22,329,108.65 | 11,990,595.13 | 23,978,763.65 | 13,482,490.75 |
| 毛利率(%) | |||||
| 药品(%) | 82.79 | - | 85.97 | 84.19 | 86.23 |
| 医药健康产品(%) | - | 85.45 | - | - | - |
| 内部抵销(%) | - | - | - | - | - |
| 其他(%) | 71.00 | 68.82 | 72.72 | 70.24 | 68.31 |
| 收入构成(%) | |||||
| 药品(%) | 98.27 | - | 98.59 | 98.40 | 98.29 |
| 医药健康产品(%) | - | 98.54 | - | - | - |
| 内部抵销(%) | -0.03 | - | - | - | - |
| 其他(%) | 1.76 | 1.46 | 1.41 | 1.60 | 1.71 |
| 毛利构成(%) | |||||
| 药品(%) | 98.52 | - | 98.81 | 98.66 | 98.64 |
| 医药健康产品(%) | - | 98.82 | - | - | - |
| 内部抵销(%) | -0.04 | - | - | - | - |
| 其他(%) | 1.52 | 1.18 | 1.19 | 1.34 | 1.36 |